BioPharma Drive: Drug Pricing

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Drug Research 112

Drug Research Research Drugs 112

BioPharma Drive: Drug Pricing

DECEMBER 12, 2023

Just before clearing Pfizer’s buyout of Seagen, the regulator threatened to block Sanofi’s licensing deal with Maze Therapeutics, a challenge the biotech called ‘‘unprecedented.”

Drug Research 120

Drug Research Licensing Licensing Research 120

BioPharma Drive: Drug Pricing

APRIL 22, 2024

A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.

Drug Research 72

Drug Research Research Drugs Production 72

BioPharma Drive: Drug Pricing

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Drug Research 121

Drug Research Research Drugs 121

BioPharma Drive: Drug Pricing

MARCH 1, 2024

The cash will be used to advance development of FOG-001, the company’s lead drug that’s now being tested in an early-stage trial for solid tumors.

Drug Research 69

Drug Research Research Drugs Trials 69

BioPharma Drive: Drug Pricing

JUNE 18, 2024

Belharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere, Regenxbio mapped a regulatory path and Taysha shared updated results for its Rett treatment.

Drug Research 69

Drug Research Research Drugs Treatment 69

BioPharma Drive: Drug Pricing

SEPTEMBER 7, 2023

The Series B round makes Mariana one of the best funded private companies in a growing group of biotechs working on new radiopharmaceutical therapies.

Drug Research 69

Drug Research Research Therapies Drugs 69

BioPharma Drive: Drug Pricing

AUGUST 22, 2023

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

Research 98

Research Drug Research Drug Development Drugs 98

BioPharma Drive: Drug Pricing

JULY 11, 2023

RA Capital led a Series B financing round that drew participation from more than a dozen blue-chip venture backers, including new investors Goldman Sachs and Vertex Ventures.

Drug Research 44

Drug Research Research Drugs 44

BioPharma Drive: Drug Pricing

JANUARY 12, 2024

Arena BioWorks, which will be led by Harvard University scientist Stuart Schreiber, seeks to blend academic and venture capital drug research models.

Drug Research 129

Drug Research Research Drugs 129

BioPharma Drive: Drug Pricing

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

Drug Research 132

Drug Research Research Drugs 132

BioPharma Drive: Drug Pricing

AUGUST 16, 2024

Some industry watchers described the level of price discounts announced by Medicare as a "relief," though they warned of bigger future implications for drug research.

Drugs 72

Drugs Drug Research Research 72

Drug Discovery World

JULY 26, 2024

‘Encouraging’ results for potential disease-modifying ALS drug New clinical data have shown that TikoMed’s low molecular weight dextran sulfate compound ILB is safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS). Fox Foundation for Parkinson’s Research (MJFF).

Vaccine 130

Vaccine Drugs Disease Therapies 130

Drug Discovery World

MAY 28, 2024

The growth will in part by driven by an increase in the use of imaging modalities in drug research and development. According to a January 2024 report by market analysts Coherent Market Insights, the global bio-imaging market was estimated to be worth $5.74 billion in 2023 and is poised to reach $15.58 from 2023 to 2030.

Drugs 130

Drugs Clinical Trials Marketing Disease 130

BioPharma Drive: Drug Pricing

DECEMBER 13, 2023

The company is now expecting to save $4 billion by the end of 2024, with a majority of the spending cuts coming from drug research and development.

Drug Research 116

Drug Research Research Drugs 116

Drug Discovery World

JUNE 21, 2024

EHA2024: Industry shares latest drug research in blood cancers A number of key findings in haematological malignancies were revealed at this year’s European Hematology Association (EHA) Congress, which was held in Madrid, Spain 13-16 June.

Therapies 147

Therapies Drugs Trials FDA 147

Drug Discovery World

JULY 24, 2024

SynaptixBio and Evotec have announced they are extending their partnership to find further candidate drugs to treat H-ABC, the most severe form of TUBB4A leukodystrophy.

Therapies 130

Therapies Disease Clinical Trials Hospitals 130

Drugs.com

OCTOBER 24, 2023

23, 2023 -- New research suggests a link between middle school students being disciplined for marijuana use and legalization of recreational weed, particularly when schools are close to dispensaries that sell the drug. Researchers. MONDAY, Oct.

Drugs 110

Drugs Drug Research Research 110

Chemical Biology and Drug Design

JULY 5, 2024

Abstract Intestinal absorption of compounds is significant in drug research and development. The QSPR model accurately predicted the intestinal absorption of molecules, and the computer simulation found the mechanism of molecular structure affecting intestinal absorption.

Drug Research 100

Drug Research Research Drugs 100

BioPharma Drive: Drug Pricing

AUGUST 15, 2023

More than a dozen startups have joined a few publicly traded biotechs and larger pharmaceutical firms in what’s become one of the most competitive areas in drug research.

Pharmaceuticals 98

Pharmaceuticals Drug Research Research Drugs 98

BioPharma Drive: Drug Pricing

JULY 5, 2023

The deal enables Sarepta to quickly cash in on the clearance of Elevidys, with $102 million in new funds to help bankroll its drug research.

Therapies 107

Therapies FDA Drug Research Research 107

BioPharma Drive: Drug Pricing

MARCH 12, 2024

Allogene’s partnership with Arbor is designed to help the company stand out in what’s quickly become one of the industry’s hottest areas of drug research.

Disease 72

Disease Therapies Drug Research Research 72

BioPharma Drive: Drug Pricing

FEBRUARY 28, 2024

Well-known scientist and biotech entrepreneur Robert Langer is helping Lindus Health address longstanding challenges in contract drug research.

Drug Research 61

Drug Research Research Drugs 61

Drug Discovery World

SEPTEMBER 2, 2022

Explora BioLabs and CRADL allow clients to launch or expand their drug research programs, with access to Charles River’s complete portfolio of integrated drug discovery and non-clinical development resources. CRADL has also added additional facilities in South San Francisco and a new location in Thousand Oaks.

Laboratories 130

Laboratories Clinical Development Drug Research Drugs 130

Cytel

JUNE 19, 2024

Historically, many drugs have been prescribed to children even though this patient population have largely been excluded from clinical trials. There is an obvious logic. If medicines are to be used in children, they need to be studied in pediatric populations to ensure they are safe and effective.

Clinical Trials 59

Clinical Trials Regulations Pharmaceuticals Drug Research 59

BioPharma Drive: Drug Pricing

JUNE 14, 2023

The alliance is Astellas’ second recent partnership involving protein degraders, an emerging area of drug research the company has made a focus in recent years.

Drugs 69

Drugs Drug Research Research 69

Drug Discovery World

JULY 17, 2023

Paul Denslow , CEO, Intus Bio, discusses how a new approach to tracking gut bacteria can revolutionse our understanding of the microbiome and bring about new discoveries for therapeutics. It’s a long-held doctrine that there’s no effective method to track the microbiome during drug research and development.

Drugs 130

Drugs Immune Response Drug Development Drug Research 130

BioPharma Drive: Drug Pricing

JULY 6, 2023

The contract services provider, which secured the deal through a reportedly competitive process, expects CorEvitas to expand its drug research business.

Drug Research 52

Drug Research Research Drugs 52

Drug Discovery World

AUGUST 2, 2023

The encyclopaedia, developed by a team of researchers and clinicians led by The Institute of Cancer Research, London, comprises data from 321 people with 11 different types of sarcoma tumours. New targeted drugs Researchers looked at patient samples to uncover the ‘proteomic profile’ of the sarcoma tumours.

Treatment 130

Treatment Research Drug Research Drugs 130

BioPharma Drive: Drug Pricing

JULY 26, 2023

The startup, which initially aims to make cancer medicines, claims to have a new twist on covalent drug research.

Drugs 52

Drugs Drug Research Research 52

Sygnature Discovery

SEPTEMBER 14, 2023

Sygnature Discovery is delighted to announce that its customer, River BioMedics , has raised an additional €2M in seed funding to continue its life-saving cardiovascular drug research. The biotech’s aim is to develop medicines that treat the underlying cause of heart failure rather than merely treating the symptoms.

Small Molecule 52

Small Molecule Assay Development Disease Drug Research 52

Vial

MAY 20, 2024

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7 billion in 2022 and is projected to reach US$10.2

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Discovery World

MARCH 22, 2023

The collaboration seeks to validate novel drug targets that are causally linked to clinical endpoints in Huntington’s disease. It is estimated that Huntington’s disease affects approximately 1 in 10,000 people worldwide and currently there is no cure and treatment options are limited.

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Small Molecule Licensing 130

Drug Channels

MARCH 5, 2024

The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Pharmacies and Pharmacy Benefit Managers. Read on for full details on pricing and registration.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Discovery World

JUNE 14, 2023

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia.

Science 130

Science Pharmaceutical Companies Pharmaceuticals Research 130

DrugBank

SEPTEMBER 12, 2024

Data Exploration If you’re venturing into a new area of drug research, the Data Dictionary helps you identify relevant data fields and understand their context. Together, let’s leverage the power of well-defined, transparent data to accelerate innovation in drug research and development.

Production 77

Production Government Packaging Compliance 77

DrugBank

AUGUST 20, 2024

The Power of Drug Repurposing Explore the immense potential of drug repurposing as a strategy for targeting undruggable targets. By identifying new uses for existing drugs, researchers can significantly reduce development time and costs.

Pharmaceuticals 71

Pharmaceuticals Therapies Research Disease 71